E-LIB Suche - Ergebnisse für: Krebs, M.G.

1

6MO Subcutaneous amivantamab administered every 4 weeks (Q4..:

Leighl, N. ; Minchom, A.R. ; Lee, K.H.H....
ESMO Open. 9 (2024) - p. 102585 , 2024

Link: https://doi.org/10.1016/..

2

Social determinants of health inequalities in early phase c..:

Rae, S. ; Shaya, S. ; Taylor, E....
British Journal of Cancer. , 2024

Link: https://doi.org/10.1038/..

3

86O Serial monitoring of circulating tumor DNA (ctDNA) as a..:

Shohdy, K.S. ; Franco, A. Ortega ; Saud, A....
ESMO Open. 9 (2024) - p. 102312 , 2024

Link: https://doi.org/10.1016/..

4

80P Social determinants of health inequalities in early pha..:

Rae, S.C.A. ; Shaya, S.J. ; Taylor, E....
ESMO Open. 9 (2024) - p. 102308 , 2024

Link: https://doi.org/10.1016/..

5

11MO Final data from a phase II study (TACTI-002) of eftila..:

Majem, M. ; Forster, M.D. ; Krebs, M.G....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S43-S44 , 2023

Link: https://doi.org/10.1016/..

6

82TiP A modular, open-label, phase I/II study to evaluate t..:

Gianoukakis, A.G. ; Arnold, S.M. ; Kahn, S.A....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S87-S88 , 2023

Link: https://doi.org/10.1016/..

7

OA21.04 Amivantamab in Patients with Advanced NSCLC and MET..:

Leighl, N. ; Cho, B.C. ; Hiret, S....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S93-S94 , 2023

Link: https://doi.org/10.1016/..

8

158P Enhancing the communication of genomic results: Unders..:

Johnston, E. ; Nicholls, G. ; Goodwin, L....
ESMO Open. 8 (2023) 1 - p. 102007 , 2023

Link: https://doi.org/10.1016/..

9

124MO A single centre experience of patients with rare canc..:

Angelakas, A. ; Cook, N. ; Graham, D.M....
ESMO Open. 8 (2023) 1 - p. 101070 , 2023

Link: https://doi.org/10.1016/..

10

TARGET National: A UK-wide Liquid-based Molecular Profiling..:

Ortega-Franco, A. ; Darlington, E. ; Greystoke, A..
Clinical Oncology. 35 (2023) 1 - p. 33-37 , 2023

Link: https://doi.org/10.1016/..

11

EPIC: an evaluation of the psychological impact of early-ph..:

Jittla, P. ; Graham, D.M. ; Zhou, C....
ESMO Open. 7 (2022) 5 - p. 100550 , 2022

Link: https://doi.org/10.1016/..

12

OA03.04 Phase I A Study to Evaluate GDC-6036 Monotherapy in..:

Sacher, A. ; Patel, M.R. ; Miller Jr., W.H....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S8-S9 , 2022

Link: https://doi.org/10.1016/..

13

PB2099: A FIRST-IN-HUMAN PHASE 1 TRIAL OF NX-1607, A FIRST-..:

Sharp, A. ; Williams, A. ; Blagden, S....
HemaSphere. 6 (2022) - p. 1970-1971 , 2022

Link: https://doi.org/10.1097/..

14

Intrapatient comparisons of efficacy in a single-arm trial ..:

Krebs, M.G. ; Blay, J.-Y. ; Le Tourneau, C....
ESMO Open. 6 (2021) 2 - p. 100072 , 2021

Link: https://doi.org/10.1016/..

15

Genomic context of NTRK1/2/3 fusion-positive tumours from a..:

Westphalen, C. B. ; Krebs, M. G. ; Le Tourneau, C....
npj Precision Oncology. 5 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..